September 30, 2016 12:40 PM ET


Company Overview of Traversa Therapeutics, Inc.

Company Overview

Traversa Therapeutics, Inc., a preclinical-stage biopharmaceutical company, engages in the discovery, design, development, and commercialization of RNA interference delivery technologies. The company’s short interfering RNA (siRNA) delivery technology avoids the physical size and bioavailability problems inherent in the liposome/cationic-lipid approach, as well as supports delivery to primary and tumor cells, T cells, B cells, macrophage, neuronal cells, and human stem cells. The siRNA technology helps RNA interference therapeutic companies in targeting a variety of acute, chronic, and infectious human diseases. The company’s technologies are used in pharmaceutical companies and RNA interfer...

10480 Wateridge Circle

San Diego, CA 92121-5773

United States

Founded in 2006



Key Executives for Traversa Therapeutics, Inc.

Chief Executive Officer and President
Founder and Member of Advisory Board
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Traversa Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at